Regulatory UpdatesAug 30, 2026•1 min read

FDA Discontinues Methotrexate Sodium Injection (ANDA089309)

By the PharmaCountry team

The FDA has listed Quad Pharms' methotrexate sodium injection (product 001) as discontinued under ANDA089309.

The U.S. Food and Drug Administration (FDA) has recorded the methotrexate sodium injection (product number 001) from sponsor Quad Pharms as discontinued. The product is an injectable formulation with a strength of EQ 25 mg base per mL. It is not designated as a reference drug, and its marketing status is listed as discontinued under application number ANDA089309.

Compiled by the PharmaCountry team · Source: FDA.gov

Topics:#Methotrexate #injection #FDA #ANDA #discontinued #Quad Pharms